The landscape for clinical trial data sharing is evolving rapidly. European Medicines Agency’s (EMA) Policy 0070 requires sponsors to publicly disclose clinical data for medicinal products in the European Union. It was suspended after Brexit and the COVID-19 pandemic. With the 2023 Policy 0070 relaunch, pharmaceutical companies face new challenges and opportunities in data transparency and disclosure.
Submit the form to download your copy and streamline your approach to clinical trial disclosure.